SUDARSHAN PHARMA INDUSTRIES LI Share Price
SUDARSHAN PHARMA INDUSTRIES LI Share Price Today
As of 3 Sep 2026, SUDARSHAN PHARMA INDUSTRIES LI share price is ₹38.50. The stock opened at ₹37.86, compared to its previous close of ₹39.09. During today's trading session, SUDARSHAN PHARMA INDUSTRIES LI share price moved in the range of ₹37.86 to ₹38.50, with an average price of ₹38.18 for the day. Looking at its last 52-week, the stock has touched a low of ₹18.50 and a high of ₹42.79.
SUDARSHAN PHARMA INDUSTRIES LI Returns Calculator
About SUDARSHAN PHARMA INDUSTRIES LI
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.
SUDARSHAN PHARMA INDUSTRIES LI Financial Highlights
- Revenue: SUDARSHAN PHARMA INDUSTRIES LI reported revenue of ₹711.77 crore in FY26 vs ₹507.70 crore in FY25. It showed an increase of 40.19% on a yearly basis.
- Operating Profit: SUDARSHAN PHARMA INDUSTRIES LI reported an operating profit of ₹30.54 crore in FY26 vs ₹20.02 crore in FY25. It showed an increase of 52.55% on a year-on-year basis.
- Net Profit: SUDARSHAN PHARMA INDUSTRIES LI reported a net profit of ₹23.37 crore in FY26 vs ₹14.97 crore in FY25. It showed an increase of 56.11% on a yearly basis.
SUDARSHAN PHARMA INDUSTRIES LI Quarterly Result Highlights
- SUDARSHAN PHARMA INDUSTRIES LI reported revenue of ₹175.64 crore in Jun 2026, compared with ₹225.05 crore in Mar 2026, representing a decrease of 21.96% on a quarter-on-quarter (QoQ) basis.
- SUDARSHAN PHARMA INDUSTRIES LI reported an operating profit of ₹7.51 crore in Jun 2026, compared with ₹15.70 crore in Mar 2026, representing a decrease of 52.17% on a quarter-on-quarter (QoQ) basis.
- SUDARSHAN PHARMA INDUSTRIES LI reported a profit of ₹5.61 crore in Jun 2026, compared with ₹11.39 crore in Mar 2026, reflecting a decrease of 50.75% on a QoQ basis.
- The earnings per share (EPS) of SUDARSHAN PHARMA INDUSTRIES LI stood at ₹0.66 during Jun 2026.
| Dec 2025 | 19.78% |
|---|---|
| Mar 2026 | 19.95% |
| Jun 2026 | 19.38% |
| Aug 2026 | 19.87% |
SUDARSHAN PHARMA INDUSTRIES LI Shareholder Returns
SUDARSHAN PHARMA INDUSTRIES LI Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Pidilite Industries | 1,66,566.00 | 62.24 | 15.38 | 22.61% | 0.03 | 29.97% | 104.78 | 0.70% | 0.98 | 23.43 |
| SRF | 76,535.40 | 35.61 | 5.48 | 13.07% | 0.27 | 13.18% | 426.52 | 0.35% | 0.65 | 58.18 |
| Linde India | 54,415.50 | 99.17 | 12.70 | 12.87% | 0.02 | 17.16% | 495.72 | 0.19% | 0.46 | 64.59 |
| Gujarat Fluorochemicals | 51,972.80 | 86.62 | 6.65 | 7.13% | 0.22 | 8.93% | 647.23 | 0.06% | 0.47 | 61.69 |
| Navin Fluorine | 43,813.70 | 55.48 | 11.02 | 16.69% | 0.03 | 18.14% | 714.37 | 0.10% | 0.56 | 96.03 |
| Godrej Industries | 38,352.20 | 17.36 | 3.43 | 11.10% | 6.25 | 9.34% | 52.52 | 0.00% | 0.36 | 1.81 |
| Himadri Speciality Chemicals | 33,312.00 | 41.42 | 7.08 | 15.96% | 0.16 | 19.45% | 91.62 | 0.12% | 0.75 | 15.05 |
| Deepak Nitrite | 23,645.80 | 30.18 | 4.05 | 9.43% | 0.02 | 10.74% | 235.74 | 0.43% | 0.74 | 13.85 |
| Aether Industries | 21,847.70 | 92.89 | 8.90 | 8.94% | 0.15 | 10.61% | 1,725.26 | 0.00% | 0.33 | 13.09 |
| Aarti Industries | 18,334.00 | 34.53 | 3.08 | 7.04% | 0.83 | 6.41% | 164.64 | 0.20% | 0.75 | 11.65 |
SUDARSHAN PHARMA INDUSTRIES LI Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹505.05 | ₹463.54 | ₹461.33 | ₹357.09 |
| Other Income | ₹2.52 | ₹2.61 | ₹1.12 | ₹0.46 |
| Total Revenue | ₹507.57 | ₹466.15 | ₹462.45 | ₹357.56 |
| Total Expenses | ₹483.12 | ₹450.92 | ₹452.95 | ₹350.42 |
| Profit Before Tax | ₹21.63 | ₹15.23 | ₹9.50 | ₹7.14 |
| Tax | ₹5.68 | ₹3.77 | ₹2.46 | ₹1.89 |
| Profit After Tax | ₹15.95 | ₹11.46 | ₹7.04 | ₹5.25 |
| EPS - Basic | ₹0.66 | ₹4.76 | ₹5.48 | ₹5.46 |
| EPS - Diluted | ₹0.66 | ₹4.76 | ₹5.48 | ₹5.46 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹21.63 | ₹15.23 | ₹9.50 | ₹7.14 |
| Income before WC changes | ₹41.64 | ₹24.63 | ₹15.32 | ₹11.18 |
| Change in Assets | -₹100.01 | -₹52.18 | -₹57.56 | -₹42.96 |
| Change in Liabilities | ₹96.53 | ₹35.72 | ₹15.56 | ₹29.72 |
| Change in WC | -₹3.48 | -₹16.46 | -₹42.00 | -₹13.24 |
| Cash flow from Operations | ₹35.22 | ₹6.01 | -₹28.79 | -₹3.82 |
| Cash flow from Investing | -₹20.41 | -₹5.49 | -₹25.65 | -₹1.46 |
| Cash flow from Financing | -₹14.45 | -₹12.10 | ₹65.93 | ₹4.26 |
| Total Cash Flow | ₹0.37 | -₹11.58 | ₹11.48 | -₹1.02 |
| Cash (Start of the year) | ₹0.14 | ₹11.72 | ₹0.24 | ₹1.25 |
| Cash (End of the year) | ₹0.55 | ₹0.14 | ₹11.72 | ₹0.24 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹67.56 | ₹41.55 | ₹33.86 | ₹7.94 |
| Current Assets | ₹334.85 | ₹241.57 | ₹198.62 | ₹129.58 |
| Total Assets | ₹402.41 | ₹283.13 | ₹232.48 | ₹137.52 |
| Current Liabilities | ₹259.69 | ₹160.82 | ₹118.48 | ₹102.62 |
| Net Current Asset | ₹75.15 | ₹80.75 | ₹80.14 | ₹26.96 |
| Non-Current Liabilities | ₹11.23 | ₹10.59 | ₹13.03 | ₹5.12 |
| Equity Capital | ₹131.48 | ₹111.71 | ₹100.97 | ₹29.78 |
| Total Equity & Liabilities | ₹402.41 | ₹283.13 | ₹232.48 | ₹137.52 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹502.51 | ₹465.56 | ₹461.33 | ₹357.09 |
| Other Income | ₹2.88 | ₹2.75 | ₹1.12 | ₹0.46 |
| Total Revenue | ₹505.38 | ₹468.31 | ₹462.45 | ₹357.56 |
| Total Expenses | ₹481.28 | ₹453.22 | ₹452.95 | ₹350.42 |
| Profit Before Tax | ₹21.29 | ₹15.10 | ₹9.50 | ₹7.14 |
| Tax | ₹5.41 | ₹3.74 | ₹2.46 | ₹1.89 |
| Profit After Tax | ₹15.88 | ₹11.36 | ₹7.04 | ₹5.25 |
| EPS - Basic | ₹0.66 | ₹0.47 | ₹5.48 | ₹5.46 |
| EPS - Diluted | ₹0.66 | ₹0.47 | ₹5.48 | ₹5.46 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹21.29 | ₹15.10 | ₹9.50 | ₹7.14 |
| Income before WC changes | ₹40.21 | ₹24.42 | ₹15.32 | ₹11.22 |
| Change in Assets | -₹95.54 | -₹55.03 | -₹57.56 | -₹42.85 |
| Change in Liabilities | ₹93.07 | ₹42.42 | ₹15.56 | ₹29.71 |
| Change in WC | -₹2.46 | -₹12.62 | -₹42.00 | -₹13.15 |
| Cash flow from Operations | ₹34.91 | ₹9.69 | -₹28.79 | -₹3.70 |
| Cash flow from Investing | -₹20.24 | -₹9.08 | -₹25.65 | -₹1.54 |
| Cash flow from Financing | -₹14.41 | -₹12.18 | ₹65.93 | ₹4.31 |
| Total Cash Flow | ₹0.26 | -₹11.58 | ₹11.48 | -₹0.93 |
| Cash (Start of the year) | ₹0.13 | ₹11.71 | ₹0.23 | ₹1.15 |
| Cash (End of the year) | ₹0.39 | ₹0.13 | ₹11.71 | ₹0.23 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹66.57 | ₹43.99 | ₹33.96 | ₹8.04 |
| Current Assets | ₹333.83 | ₹240.85 | ₹198.51 | ₹129.47 |
| Total Assets | ₹400.40 | ₹284.84 | ₹232.47 | ₹137.51 |
| Current Liabilities | ₹257.98 | ₹162.27 | ₹118.46 | ₹102.61 |
| Net Current Asset | ₹75.85 | ₹78.58 | ₹80.05 | ₹26.86 |
| Non-Current Liabilities | ₹11.10 | ₹10.96 | ₹13.03 | ₹5.12 |
| Equity Capital | ₹131.31 | ₹111.62 | ₹100.98 | ₹29.78 |
| Total Equity & Liabilities | ₹400.40 | ₹284.84 | ₹232.47 | ₹137.51 |
| 3 Sep | 0L |
|---|---|
| 2 Sep | 37L |
| 1 Sep | 0L |
| 31 Aug | 2L |
| 28 Aug | 2L |
| 27 Aug | 0L |
| Average | 7L |
Popular Stocks
SUDARSHAN PHARMA INDUSTRIES LI Share Price FAQs
What is SUDARSHAN PHARMA INDUSTRIES LI share price today?
SUDARSHAN PHARMA INDUSTRIES LI share price is ₹38.50 as on 03 Sep, 2026, 13:36 IST.
How has the SUDARSHAN PHARMA INDUSTRIES LI share price performed in the past?
In the last 1 year, SUDARSHAN PHARMA INDUSTRIES LI delivered a return of 21.70%. The SUDARSHAN PHARMA INDUSTRIES LI share price hit a high of ₹42.79 and low of ₹18.50.
How much is the Mutual Fund shareholding in SUDARSHAN PHARMA INDUSTRIES LI shares?
The Mutual Fund Shareholding in SUDARSHAN PHARMA INDUSTRIES LI was 0.00% at the end of Aug 2026.
What is the the 52-week high and low of SUDARSHAN PHARMA INDUSTRIES LI shares ?
The 52-week high and low of SUDARSHAN PHARMA INDUSTRIES LI share is ₹42.79 and ₹18.50 as of 03 Sep, 2026.
What is the market cap of SUDARSHAN PHARMA INDUSTRIES LI?
The market capitalisation of SUDARSHAN PHARMA INDUSTRIES LI is ₹975.92 Crores as on 03 Sep, 2026.
What are the stock symbols of SUDARSHAN PHARMA INDUSTRIES LI?
The stock symbol of SUDARSHAN PHARMA INDUSTRIES LI is 543828 on the BSE, and the ISIN is INE00TV01023.
What was yesterday's closing price for SUDARSHAN PHARMA INDUSTRIES LI shares ?
SUDARSHAN PHARMA INDUSTRIES LI shares closed yesterday at ₹39.09 on BSE
How to buy SUDARSHAN PHARMA INDUSTRIES LI shares?
To buy SUDARSHAN PHARMA INDUSTRIES LI shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SUDARSHAN PHARMA INDUSTRIES LI shares on Holidays?
No, shares of SUDARSHAN PHARMA INDUSTRIES LI or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SUDARSHAN PHARMA INDUSTRIES LI shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SUDARSHAN PHARMA INDUSTRIES LI?
The PE and PB ratio of SUDARSHAN PHARMA INDUSTRIES LI is 39.09 and 5.73 respectively, as on 03 Sep, 2026, 13:36 IST.